SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The Changing Face of the Cost-Utility Literature, 1990–2012
14 references·7 citing·29 second hop
The Changing Face of the Cost-Utility Literature, 1990–2012 (2015)The Changing Face of the Cost-Utility Lit…Cost-Effectiveness in Health and Medicine (2016)Cost-Effectiveness in Health …Legislating against Use of Cost-Effectiveness Information (2010)Legislating against Use of Co…Methods for the economic evaluation of health care programmes, 3rd ed (2006)Methods for the economic eval…Methods for the Economic Evaluation of Health Care Programmes (2005)Methods for the Economic Eval…Growth and Quality of the Cost–Utility Literature, 1976–2001 (2005)Growth and Quality of the Cos…The Quality of Reporting in Published Cost-Utility Analyses, 1976–1997 (2000)The Quality of Reporting in P…Guidelines for Pharmacoeconomic Studies (1997)Guidelines for Pharmacoeconom…Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine (1996)Recommendations for reporting…Recommendations for Reporting Cost-effectiveness Analyses (1996)Recommendations for Reporting…Panel on cost-effectiveness in health and medicine. (1996)Panel on cost-effectiveness i…Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)Guidelines for authors and pe…Cost-Effectiveness in Health and Medicine (1996)Cost-Effectiveness in Health …Guidelines for pharmacoeconomic studies. (1992)Guidelines for pharmacoeconom…Methods for the economic evaluation of health care programmes (1987)Methods for the economic eval…Developing Criteria for Health Economic Quality Evaluation Tool (2023)Developing Criteria for Healt…Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations (2022)Consolidated Health Economic …Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations (2022)Consolidated Health Economic …Use of Checklists in Reviews of Health Economic Evaluations, 2010 to 2018 (2018)Use of Checklists in Reviews …The influence of time horizon on results of cost-effectiveness analyses (2017)The influence of time horizon…A Systematic Review of Cost-Effectiveness Studies Reporting Cost-per-DALY Averted (2016)A Systematic Review of Cost-E…Measuring the Sensitivity and Construct Validity of 6 Utility Instruments in 7 Disease Areas (2015)Measuring the Sensitivity and…Quality of life and pharmacoeconomics in clinical trials (1996)Inductive Teaching and Learning Methods: Definitions, Comparisons, and Research Bases (2006)Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement (2013)Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations (2022)Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1996)The economic value of personalized medicine tests: what we know and what we need to know (2013)Evidence-informed frameworks for cost-effective cancer care and prevention in low, middle, and high-income countries (2014)A Health Opportunity Cost Threshold for Cost-Effectiveness Analysis in the United States (2020)Dynamics of a stressful encounter: Cognitive appraisal, coping, and encounter outcomes. (1986)Examining the Value and Quality of Health Economic Analyses: Implications of Utilizing the QHES (2003)Health Care Economic Analyses and Value-Based Medicine (2003)Searching for the structure of coping: A review and critique of category systems for classifying ways of coping. (2003)Systematic review of economic analyses of health care-associated infections (2005)Using thematic analysis in psychology (2006)EQ-SD: a measure of health status from the EuroQol Group (2001)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)The estimation of a preference-based measure of health from the SF-36 (2002)Systematic reviews: CRD's guidance for undertaking reviews in health care (2010)The development of a financial toxicity patient‐reported outcome in cancer: The COST measure (2014)Thresholds for the cost–effectiveness of interventions: alternative approaches (2014)Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report (2015)Measurement of health state utilities for economic appraisal (1986)The Estimation of a Preference-Based Measure of Health From the SF-12 (2004)Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force (2022)Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force Report (2005)International survey on willingness‐to‐pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? (2009)Defining Elements of Value in Health Care—A Health Economics Approach: An ISPOR Special Task Force Report [3] (2018)Simulating the Potential Impacts of COVID-19 School Closures on Schooling and Learning Outcomes: A Set of Global Estimates (2020)
this work references cited by second hop

References

  • 2005Methods for the Economic Evaluation of Health Care Programmes13,647 cited
  • 1996Cost-Effectiveness in Health and Medicine7,192 cited
  • 1987Methods for the economic evaluation of health care programmes4,274 cited
  • 1996Guidelines for authors and peer reviewers of economic submissions to the BMJ1,821 cited
  • 2016Cost-Effectiveness in Health and Medicine1,550 cited
  • 1996Recommendations for Reporting Cost-effectiveness Analyses1,146 cited
  • 1996Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine1,037 cited
  • 2006Methods for the economic evaluation of health care programmes, 3rd ed956 cited
  • 1996Panel on cost-effectiveness in health and medicine.492 cited
  • 2010Legislating against Use of Cost-Effectiveness Information251 cited
  • 1997Guidelines for Pharmacoeconomic Studies233 cited
  • 1992Guidelines for pharmacoeconomic studies.224 cited
  • 2000The Quality of Reporting in Published Cost-Utility Analyses, 1976–1997208 cited
  • 2005Growth and Quality of the Cost–Utility Literature, 1976–2001161 cited

Cited by

  • 2017The influence of time horizon on results of cost-effectiveness analyses

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

103 cited
  • 2018Use of Checklists in Reviews of Health Economic Evaluations, 2010 to 201897 cited
  • 2022Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations95 cited
  • 2016A Systematic Review of Cost-Effectiveness Studies Reporting Cost-per-DALY Averted92 cited
  • 2015Measuring the Sensitivity and Construct Validity of 6 Utility Instruments in 7 Disease Areas88 cited
  • 2022Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations76 cited
  • 2023Developing Criteria for Health Economic Quality Evaluation Tool74 cited